BRPI0517024A - conjugados com atividade antiinflamatória - Google Patents

conjugados com atividade antiinflamatória

Info

Publication number
BRPI0517024A
BRPI0517024A BRPI0517024-9A BRPI0517024A BRPI0517024A BR PI0517024 A BRPI0517024 A BR PI0517024A BR PI0517024 A BRPI0517024 A BR PI0517024A BR PI0517024 A BRPI0517024 A BR PI0517024A
Authority
BR
Brazil
Prior art keywords
inflammatory activity
steroid
xiii
nonsteroidal
substructure
Prior art date
Application number
BRPI0517024-9A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Linda Tomaskovic
Stribor Markovic
Visnja Poljak
Gordana Sijan
Selvira Selmani
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Publication of BRPI0517024A publication Critical patent/BRPI0517024A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

CONJUGADOS COM ATIVIDADE ANTIINFLAMATóRIA A presente invenção refere-se a novos Compostos representados pela Fórmula I: onde M representa uma subunidade macrolida da subestrutura VIII: L representa a cadeia da subestrutura IX ou XIII: Z representa a subunidade esteróide ou não esteroidal derivada de drogas esteróides ou não esteroidais (NSAID) com atividade antiinflamatória. A presente invenção refere-se ainda aos sais farmaceuticamente aceitáveis e solvatos de tais Compostos preparados, a processos e intermediários para sua preparação, bem como a ação terapêutica melhorada e ao uso no tratamento de doenças e condições inflamatórias em humanos e animais.
BRPI0517024-9A 2004-10-27 2005-10-27 conjugados com atividade antiinflamatória BRPI0517024A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62315404P 2004-10-27 2004-10-27
PCT/IB2005/003213 WO2006046123A2 (en) 2004-10-27 2005-10-27 Conjugates with anti-inflammatory activity

Publications (1)

Publication Number Publication Date
BRPI0517024A true BRPI0517024A (pt) 2008-03-25

Family

ID=36097295

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517024-9A BRPI0517024A (pt) 2004-10-27 2005-10-27 conjugados com atividade antiinflamatória

Country Status (17)

Country Link
US (1) US20090048221A1 (pt)
EP (2) EP1805202B1 (pt)
JP (1) JP2008517993A (pt)
KR (1) KR20070083811A (pt)
CN (1) CN101090908A (pt)
AT (1) ATE453658T1 (pt)
AU (1) AU2005298312A1 (pt)
BR (1) BRPI0517024A (pt)
CA (1) CA2585711A1 (pt)
DE (1) DE602005018672D1 (pt)
ES (1) ES2337915T3 (pt)
IL (1) IL182694A0 (pt)
MX (1) MX2007005073A (pt)
NO (1) NO20072684L (pt)
RU (1) RU2007119577A (pt)
WO (1) WO2006046123A2 (pt)
ZA (1) ZA200702579B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337915T3 (es) * 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
FR2909876A1 (fr) * 2006-12-19 2008-06-20 Galderma Res & Dev S N C Snc Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
KR101245078B1 (ko) * 2010-11-11 2013-03-18 부산대학교 산학협력단 대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
CA2908620A1 (en) 2013-04-10 2014-10-16 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
JP2020517748A (ja) 2017-04-20 2020-06-18 ライジング タイド ファウンデーション 抗がん剤としてホスホニウムイオンを含むアジスロマイシン誘導体
US11427606B2 (en) 2017-04-20 2022-08-30 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
RS64436B1 (sr) 2018-09-14 2023-09-29 Enlitisa Shanghai Pharmaceutical Co Ltd Konjugati montelukasta i peptida
CN111170959A (zh) * 2019-12-30 2020-05-19 南开大学 一种大环内酯化合物的晶型及其制备方法与用途
CN112521398B (zh) * 2020-07-30 2022-03-15 上海交通大学医学院附属仁济医院 一种海绵共附生菌来源开环重排甾体化合物及其制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257956B2 (en) 1986-08-19 2000-11-22 Genentech, Inc. Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion
DE3860503D1 (de) 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
SE9100341D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
GB9225923D0 (en) 1992-12-11 1993-02-03 Rhone Poulenc Rorer Ltd New compositions of matter
CA2149777C (en) 1992-12-24 2004-05-25 Michael John Ashton New steroids
WO1996004920A1 (fr) 1994-08-12 1996-02-22 Taisho Pharmaceutical Co., Ltd. Inhibiteur de production de l'interleukine-5
KR970704455A (ko) 1994-08-12 1997-09-06 우에하라 아끼라 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)
DE19616573C2 (de) 1996-04-25 1999-03-04 Pari Gmbh Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JP3530004B2 (ja) 1998-02-06 2004-05-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
WO2000025776A1 (en) 1998-10-30 2000-05-11 Nitromed, Inc. Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
IT1306205B1 (it) 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
HRP20000310A2 (en) 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
FI110835B (fi) 2000-07-11 2003-03-31 Radiolinja Ab Menetelmä palvelunumeropuhelun tarjoamiseksi matkaviestintilaajalle ennalta määrätyllä taksalla
HRP20010018A2 (en) * 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
US20050171342A1 (en) 2002-02-15 2005-08-04 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
PL374646A1 (en) 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
EP1551865B1 (en) 2002-07-08 2009-04-22 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules
CA2489402A1 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
BRPI0514254A (pt) * 2004-08-12 2008-06-03 Glaxosmithkline Zagreb uso de conjugados célula-especìficos para o tratamento de doenças inflamatórias do trato gastrintestinal
ES2337915T3 (es) * 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.

Also Published As

Publication number Publication date
AU2005298312A1 (en) 2006-05-04
EP1805202B1 (en) 2009-12-30
NO20072684L (no) 2007-07-11
CA2585711A1 (en) 2006-05-04
CN101090908A (zh) 2007-12-19
US20090048221A1 (en) 2009-02-19
JP2008517993A (ja) 2008-05-29
KR20070083811A (ko) 2007-08-24
MX2007005073A (es) 2007-06-25
ATE453658T1 (de) 2010-01-15
ES2337915T3 (es) 2010-04-30
WO2006046123A2 (en) 2006-05-04
IL182694A0 (en) 2007-09-20
ZA200702579B (en) 2008-08-27
EP1805202A2 (en) 2007-07-11
DE602005018672D1 (de) 2010-02-11
RU2007119577A (ru) 2008-12-10
EP2196469A1 (en) 2010-06-16
WO2006046123A3 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
NO20072684L (no) Konjugater med anti-inflammatorisk aktivitet
NO20055535L (no) Makrodkonjugater med anti-inflammatorisk aktivitet
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
EA017278B9 (ru) Соединения азаиндазола и способы применения
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
DE602005021150D1 (de) 3-substituierte pyridinderivate als h3-antagonisten
ATE384058T1 (de) Thiazolderivate
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
GEP20084519B (en) 3-(4-heteroarylcyclo-hexylamino) cyclopenta-necarboxamides as modulators of chemokine receptors
DE602005023197D1 (de) -muscarinrezeptors
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
DE602006014305D1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
BRPI0510024A (pt) compostos e composições como modulares de ppar
SE0401342D0 (sv) Therapeutic compounds
BR0208027A (pt) Composto de n-fenilarilsulfonamida, droga contendo o composto como ingrediente ativo, intermediário para o composto, e processos para a produção do mesmo
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
NO20075209L (no) Substituerte aryl 1,4-pyrazinderivater
TW200635592A (en) Pyridyl-substituted spiro-hydantoin compounds and use thereof
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.